Award
NIH Reporter #2R44DK122903-03A1
A FIRST IN CLASS TREATMENT FOR LIVER CIRRHOSIS
Recipient
XFIBRA, INC.
Award Amount
$1,188,325.00
Ceiling
$1,188,325.00
Awarded
September 07, 2026
Identifier
2R44DK122903-03A1
NIH/NIDDK awarded a grant to XFIBRA, INC. for developing a novel treatment for liver cirrhosis, including preclinical toxicology studies of drug candidate XFB19.
Description
A grant opportunity for a project focused on developing a first-in-class treatment for liver cirrhosis, supported by the NIH/NIDDK. The project involves long-term preclinical toxicology studies of a drug candidate named XFB19, aimed at supporting future clinical trials.